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Background: The purpose of this study was to objectively compare methodological approaches that might be
utilized in designing an antimicrobial resistance (AMR) surveillance program in beef feedlot cattle. Specifically, four
separate comparisons were made to investigate their potential impact on estimates for prevalence of AMR. These
included investigating potential differences between 2 different susceptibility testing methods (broth microdilution
and disc diffusion), between 2 different target bacteria (non-type-specific E. coli [NTSEC] and Mannheimia
haemolytica), between 2 strategies for sampling feces (individual samples collected per rectum and pooled samples
collected from the pen floor), and between 2 strategies for determining which cattle to sample (cattle that were
culture-positive for Mannheimia haemolytica and those that were culture-negative).
Results: Comparing two susceptibility testing methods demonstrated differences in the likelihood of detecting
resistance between automated disk diffusion (BioMIC®) and broth microdilution (Sensititre®) for both E. coli and
M. haemolytica. Differences were also detected when comparing resistance between two bacterial organisms within
the same cattle; there was a higher likelihood of detecting resistance in E. coli than in M. haemolytica. Differences in
resistance prevalence were not detected when using individual animal or composite pen sampling strategies.
No differences in resistance prevalences were detected in E. coli recovered from cattle that were culture-positive for
M. haemolytica compared to those that were culture-negative, suggesting that sampling strategies which targeted
recovery of E. coli from M. haemolytica-positive cattle would not provide biased results.
Conclusions: We found that for general purposes, the susceptibility test selected for AMR surveillance must be
carefully chosen considering the purpose of the surveillance since the ability to detect resistance appears to vary
between these tests depending upon the population where they are applied. Continued surveillance of AMR in
M. haemolytica recovered by nasopharyngeal swab is recommended if monitoring an animal health pathogen is an
objective of the surveillance program as results of surveillance using fecal E. coli cannot be extrapolated to this
important respiratory pathogen. If surveillance of E. coli was pursued in the same population, study populations
could target animals that were culture-positive for M. haemolytica without biasing estimates for AMR in E. coli.
Composite pen-floor sampling or sampling of individuals per-rectum could possibly be used interchangeably for
monitoring resistance in E. coli.
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While several authors have suggested that there are ques-
tions that need to be addressed in order to optimize the
structure of an antimicrobial resistance (AMR) surveillance
program, many approaches have become accepted standard
practices without investigating whether they are associated
with differences in the ability to detect resistant isolates
[1-3]. Scientists developing surveillance programs have had
to rely on previous models of these systems or expert
opinion when making decisions relative to the design.
Unfortunately, this approach does not allow for evidence-
based decision making when different design aspects
have been based on suppositions that have not been
formally investigated.
Decisions regarding antimicrobial susceptibility testing
methodology and sampling approaches are crucial to
obtaining relevant estimates of AMR in any population [4].
Disk diffusion and broth microdilution are the susceptibility
tests commonly recommended for surveillance programs
[3]. Broth microdilution is often considered the “surrogate”
gold standard test for AMR when compared to disk diffu-
sion. However, this opinion is partially based on application
for clinical diagnostics rather than AMR surveillance,
and the disk diffusion test is a less expensive option
which may appeal to surveillance programs that are trying
to optimize coverage relative to available funds [5-7]. Des-
pite the putative superiority of broth microdilution over
disk diffusion, it has not been rigorously investigated
whether similar answers will be obtained using these tests
to estimate resistance prevalence as they are applied for
surveillance and other purposes. This information would
help scientists make educated choices about the relative ad-
vantages and the comparability of data obtained regarding
the apparent susceptibility of target isolates.
The bacterial agents that will be targeted by surveillance
efforts must also be considered. The organisms monitored
in AMR surveillance programs are often selected based
on significance to public health and ease of sampling,
yet relevance to the agriculture industry should also be
considered in order to maintain support and to have prac-
tical relevance when designing a farm based surveillance
program [8]. Specifically, in the beef feedlot industry, the
resistance in Escherichia coli has often been assumed to
be a reasonable surrogate for pathogens impacting cattle
and people. However, feedlot cattle are not treated with
antimicrobial drugs (AMDs) for this typically innocuous
enteric organism. Rather, AMDs are most often used in
feedlots to treat or prevent respiratory infections [8].
Mannheimia haemolytica is probably the most significant
bacterial pathogen associated with respiratory disease
syndromes in cattle and is therefore often the target
organism when treating respiratory disease in this
population [9]. Within the same cattle, it is unknown if
resistance in E. coli is systematically different from thatof M. haemolytica; therefore, using resistance in E. coli
as a surrogate marker for resistance in M. haemolytica
may not be appropriate or informative.
Another consideration when developing a farm based
AMR surveillance program includes how to incorporate
sampling strategies that minimize the inconvenience to
the producer and that do not disturb typical operations
[10]. Collecting fecal samples from individual cattle often
requires restraining cattle in chutes and is therefore labor
intensive, inconvenient, and can increase the risks for
physical injury to cattle. A less invasive and generally
more convenient approach would be to obtain samples
of multiple fecal pats from the pen floors which could
be mixed and cultured as a single composite sample
that is representative of the whole pen. Pen floor sam-
pling with pen level inferences has been successfully
implemented in previous surveillance studies, yet there
is little information about whether this type of sampling
might provide different results compared to sampling
individual samples in a surveillance program [11]. Improv-
ing our understanding of how the prevalence of AMR
varies depending on whether samples are collected from
individual cattle or from the pen floor would therefore
be a valuable tool when considering the design of a
surveillance program.
Conservation of financial and other resources is always a
concern when developing surveillance programs, especially
when programs span over long periods of time (i.e. years).
Approaches to reduce costs should be considered carefully
to ensure that there is no compromise to the validity of
the collected data. For a surveillance program with a
goal of comparing the resistances detected between 2
organisms (e.g. E. coli vs. M. haemolytica), the ability
to make the comparison is limited by the lower of the
two recovery rates. For example, E. coli is typically re-
covered from almost 100% of bovine fecal samples, but
M. haemolytica typically can only be recovered from
about 15% of live feedlot cattle using deep nasopharyn-
geal swabbing [12]. In a program where obtaining both
organisms from one individual is required, resources
could be spared by only testing E. coli isolated from cattle
positive for M. haemolytica. While E. coli isolated from
M. haemolytica negative cattle might contribute to power
for analysis of E. coli resistance, these E. coli cannot be
matched to a corresponding M. haemolytica isolate for ana-
lysis since none were recovered. However, if the manner of
selecting only a subset of E. coli isolates (i.e. only those
from M. haemolytica positive cattle) for testing creates
any systematic bias, the results lose their validity.
The overall objective of this study was to explore several
methodological approaches available for AMR surveillance
in feedlot cattle to determine if they were associated
with systematic differences in the likelihood of detecting
resistance. Analyses were conducted to compare detected
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methods, between two bacterial organisms, and between
two sampling strategies. Additionally, an approach that
might be used to identify subsets of samples to be cultured
for E. coli relative to the culture status for M. haemolytica
was evaluated for systematic bias.
Methods
Overview
Non-type specific E. coli (NTSEC) and M. haemolytica
isolates were collected as part of a longitudinal project
examining AMR in feedlot cattle (data not shown). Cattle
were randomly enrolled in the project at the time of ar-
rival at participating feedlots. Fecal samples were collected
from pen floors and individual cattle and cultured for
E. coli, while nasopharyngeal swabs were cultured for
M. haemolytica. Subsets of isolates were purposively
selected (described below) from the entire sample set
and used in evaluations of whether systematic differ-
ences in resistance prevalences were associated with
different methodological approaches. These comparisons
included 1) susceptibility in the same isolates using broth
microdilution or automated disk diffusion (for both NTSEC
and M. haemolytica); 2) detection of resistance in NTSEC
vs. M. haemolytica that were recovered from the same in-
dividuals; 3) detection of resistance in NTSEC recovered
from fecal samples were obtained per rectum vs. isolates
recovered from composite pen floor samples; 4) detection
of resistance in NTSEC recovered from cattle that were
culture-positive for M. haemolytica vs. those that were
culture-negative for M. haemolytica.
Study population
All cattle handling and sampling procedures were approved
prior to the initiation of the study by the Animal Care
Committee of the University of Calgary (Protocol Num-
ber M07031). Cattle sampled in this study were pro-
cured and managed at four western Canadian feedlots
in south central Alberta under production conditions
typical of those used at large commercial cattle feedlots
throughout western Canada and the U.S. Participating
feedlots had one-time holding capacities that ranged
between 15,000 and 20,000 cattle, with pens housing
capacities of 50-350 cattle. Commercial feedlots were
purposively selected for participation based on their
owners’ and managers’ willingness to participate, and
the ability to collect data about exposures to anti-
microbial drugs (AMDs) for individual cattle.
The cattle utilized in this study were procured through
the auction market system from throughout Canada. Vari-
ous cattle types were fed at these feedlots, including cattle
of different entry weights, age classes (calves and yearlings),
frame sizes, sources (e.g., ranch-direct and backgrounded
cattle), and sexes (steers and heifers). Cattle entering thesefeedlots typically weighed about 225-400 kg, were managed
in the feedlot for approximately 120-250 days, and were
harvested when body weights reached 550-650 kg.
All cattle enrolled in the study were managed using
the same standardized health and production procedures
as per the protocols developed by specialists overseeing
the health and production practices (FHMS). In brief, at
arrival, each animal received a unique identification ear
tag, a growth implant, vaccines against selected bacterial
and viral pathogens, and a topical avermectin anthelmintic
for parasite control. In cattle determined to have a greater
than average risk of developing respiratory disease as deter-
mined using standardized risk profiles developed by FHMS
health and production specialists, a parenteral antimicrobial
drug was also administered at the time of arrival as a
prophylactic or metaphylactic treatment. Water and feed
were offered ad libitum throughout the feeding period; all
diets were specially formulated to meet or exceed the
National Research Council nutritional requirements for
beef cattle [13]. The health of cattle was evaluated daily by
trained feedlot personnel, and animals deemed to be sick
were treated under the supervision of veterinarians using
standardized protocols developed by FHMS.Sampling procedures
Cattle were enrolled in the study from 17 September 2007
to 16 January 2010. A two stage random sampling plan
was used to determine which pens and individual cattle
within those pens were selected for enrollment. The
randomization scheme was applied throughout the study
period, so the frequency of enrollment and sampling rep-
resented the frequency with which cattle enter feedlots in
western Canada; predictably, higher volumes of cattle are
placed in feedlots in the fall and lower volumes of cattle
are placed in feedlots in the summer months. As cattle ar-
rived at the feedlot, 30% of all newly formed pens of cattle
were randomly selected for inclusion in the study using a
randomization table. Within each selected pen, 10% of all
cattle were enrolled at initial processing using a different,
individual animal randomization table.
Enrolled individual cattle were sampled twice over
the course of the study: during initial processing which
occurred shortly after arrival to the feedlot (first sample
time point) and later in the feeding period when cattle
were rehandled for a variety of standard feedlot protocols
(e.g., for replacement of growth-promoting implants)
Standard protocols for group processing of cattle varied
based upon the type of cattle being managed (i.e. calves
vs. yearlings and ranch-direct vs. backgrounded calves)
and can vary quite widely. As such, the timing for
obtaining the second samples from cattle varied from
33-202 days on feed (DOF) with an average of 95.5
DOF (median = 80.0 DOF).
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dividual cattle were sampled: 1) a nasopharyngeal swab
sample which was cultured for M. haemolytica and 2) a
fecal sample collected per-rectum which was cultured
for NTSEC. Nasopharyngeal samples were collected
in the deep pharynx using a commercially available
double guarded swab (# J273, Jorgensen Laboratories,
Inc., Loveland, CO, USA). After collection, swabs were
broken into a Cary Blair media tube (BBL CultureSwab™,
CA90001-038, VWR International, Mississauga, Ontario).
Fecal samples were collected per rectum using a new
plastic palpation sleeve for every animal, and a minimum of
4 grams of feces was placed in a vial containing modified
Cary Blair transport media (Enteric Transport Medium,
15 ml, Dalynn Biologicals Inc.) [14].
Pens were typically filled over several days, as cattle
arrived at the feedlot on different trucks and as animals
were processed and assigned to a pen. Composite fecal
samples were collected from floors of pens allocated to
the study soon after occupancy assignments were complete
(first sample time point) and near the dates when individual
animal samples were collected from animals assigned to that
pen (second sample time point). Composite pen-floor sam-
ples were obtained using a new plastic spoon by placing
approx. 0.5 to 1 g of feces that was collected from 20 fresh
fecal pats into a new plastic container (minimum 10 g feces).
The composite sample was mixed thoroughly, and approxi-
mately 4 g of feces from each container was then transferred
into a vial containing modified Cary Blair transport media
(Enteric Transport Medium, 15 ml, Cat#F01W, Dalynn
Biologicals Inc., Calgary, Alberta) [14].
Sample Transport and Data Storage–All samples
(nasopharyngeal swabs, rectal feces, and composite pen-
floor feces) were labeled with the date and the pen number
(and the individual ID for individual cattle samples),
refrigerated in a chilled cooler and transported to the
microbiology laboratory (Agriculture and Agri-Food
Canada Lethbridge Research Station, Lethbridge, Alberta)
by overnight courier.
Laboratory procedures
Upon arrival at the lab, fecal samples were kept refrigerated
at 4°C until nasopharyngeal samples were processed.
As a standard protocol for this surveillance project,
fecal samples collected per rectum from individual cat-
tle were only processed to recover NTSEC isolates if
M. haemolytica was cultured from that animal’s naso-
pharyngeal swab. This approach was used to conserve
resources while still allowing comparison of resistance
outcomes of both NTSEC and M. haemolytica obtained
from the same cattle. However, in order to evaluate whether
bias was introduced by preferentially culturing feces from
M. haemolytica positive-cattle, 225M. haemolytica-negative
cattle were purposively selected and NTSEC were culturedfrom fecal samples collected per rectum. All composite
pen-floor fecal samples were cultured and to recover
NTSEC regardless of the M. haemolytica status of cat-
tle in the pen.Nasopharyngeal swabs
Nasal swabs were aseptically removed from transport
vials and the tips were vortexed in a centrifuge tube at
high speed for 30 seconds and then allowed to sit undis-
turbed for at least 10 minutes. Samples of the suspen-
sion recovered from swabs (100 μl) were spread onto
blood agar containing 15 μg/mL bacitracin (BAC plates)
and incubated overnight at 37°C. Additional plates were
also inoculated with M. haemolytica ATCC strain 33396
and M. glucosida ATCC strain 38457 as positive controls.
Three to five colonies with morphology typical of
M. haemolytica (round, medium sized, moist, white-grey
colored colonies with some degree of hemolysis evident)
were selected for further analysis, streaked onto BAC
plates and incubated for 8-12 hrs at 37°C. Isolated col-
onies were evaluated to confirm purity and to verify that
the morphology was similar to the reference plate. Iso-
lates that were oxidase and catalase positive were pre-
liminarily identified as M. haemolytica and were stored
in 20% glycerol stocks at -80°C until further phenotypic
and genotypic characterization was conducted. After
thawing, phenotypic tests were performed using Rosco
diagnostic tablets (Diatabs®), including alpha-fucosidase,
beta-galactosidase, beta-glucosidase, beta-xylosidase, D-
xylose, esculin hydrolysis, indole, L-arabinose, maltose,
mannitol, ornithine decarboxylase, sorbitol, trehalose, and
urease [15]. A multiplex PCR assay was used as the final
confirmation for M. haemolytica isolates and all con-
firmed isolates were tested for antimicrobial susceptibility
[16]. Reference strains of M. haemolytica and M. glucosida
as well as negative controls were included in evaluations
as references for comparison.Composite and individual fecal samples
Fecal samples were processed by mixing the Cary-
Blair transport medium to create uniform slurry [14].
A sterile cotton swab was used to streak samples onto
MacConkey agar (MAC) and incubated for 24 hours
at 37°C. Isolates that fermented lactose and had ap-
propriate colony morphology were subcultured on ly-
sogeny broth (LB), incubated at 37°C overnight and
then tested for indole. A presumptive identification of
NTSEC was based on colony morphology, lactose fermen-
tation and positive indole reaction. Up to three NTSEC
colonies were selected from each individual animal’s
fecal sample as were five colonies from each composite
fecal sample, and isolates were archived for susceptibility
testing by freezing at -80°C in 30% glycerol.
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All NTSEC and M. haemolytica isolates included in these
analyses were tested for susceptibility to standardized
panels of AMDs by disk diffusion and broth microdilution
(Sensititre® panel type: CMV1AGNF). Both procedures
were conducted according to rigorously standardized pro-
tocols as proscribed by the Clinical Laboratory Standards
Institute [17]. The AMDs included on both the disk
diffusion and broth microdilution susceptibility panels
for NTSEC and M. haemolytica are listed in Tables 1, 2, 3
and 4. The antimicrobial drug panels were developed in-
dependently for surveillance purposes and as such AMDs
included on the 2 panels were not identical. Results of
disk diffusion testing were recorded as zone diameters
as determined using an automated zone measurement
system (BioMIC®), and results of broth microdilution testing
were recorded as the minimum inhibitory concentration
(MIC). Escherichia coli ATCC 25922 and Streptococcus
pneumoniae ATCC 49619 were used in quality control
assessments for both susceptibility testing procedures.
Additionally, Staphylococcus aureus ATCC 29213 was
used for quality control in the broth microdilution testing
while Staphylococcus aureus ATCC 25923 was used in the
disk diffusion testing procedures.
Interpretive criteria
Non-type specific E. coli and M. haemolytica isolates were
categorized as susceptible (S), intermediate (I), or resistant
(R) to antimicrobials using interpretive criteria published
by the Clinical and Laboratory Standards Institute (CLSI)


















CLSI = Clinical and Laboratory Standards Institute.CLSI does not have published interpretive criteria for cattle
regarding all of the drugs that were evaluated in this study.
When possible, interpretive criteria that were specific
for cattle and the test method/drug/bacteria combination
were used (e.g., breakpoints for broth microdilution
evaluating ceftiofur and M. haemolytica). When these
were not available, breakpoints for cattle regarding the
drug and other bacterial species were used. If these were
not available, then interpretive criteria published for
humans regarding bacteria-drug combinations were used.
The exceptions to this approach were that breakpoints for
broth microdilution testing of NTSEC for streptomycin
and disk diffusion testing of M. haemolytica for gentamicin.
Streptomycin breakpoints were based on criteria used by
the National Antimicrobial Resistance Monitoring System
of the USDA and FDA [22], which were established using
MIC distributions for bacteria and the presence of known
resistance genes or mutations. Gentamicin interpretive cri-
teria were based on a published evaluation [23].
Analysis
To facilitate analysis involving logistic regression, iso-
late susceptibility was dichotomized as resistant and
non-resistant (which included both intermediate and
susceptible classifications). For AMDs that did not have
a published intermediate susceptibility classification
(i.e., published reference only include values for susceptible
classification of isolates [e.g., ampicillin forM. haemolytica]),
any isolate not classified as susceptible was categorized as
being resistant. The outcome for logistic models was the
phenotypic resistance or non-resistance of each NTSECn susceptibility testing reported as minimum inhibitory
ediate Resistant Reference
2 ≥64 CLSI M100-S22, 2012
6 ≥32 CLSI M100-S22, 2012
/8 ≥32/16 CLSI M100-S22, 2012
6 ≥32 CLSI M100-S22, 2012
4 ≥8 CLSI M31-A4, 2013
2 ≥4 CLSI M100-S22, 2012
6 ≥32 CLSI M100-S22, 2012
2 ≥4 CLSI M100-S21, 2011
8 ≥16 CLSI M100-S22, 2012
2 ≥64 CLSI M100-S22, 2012
- ≥32 CLSI M100-S22, 2012
- ≥64 NARMS Executive Report 2009
- ≥512 CLSI M100-S22, 2012
8 ≥16 CLSI M100-S22, 2012
- ≥4/76 CLSI M100-S22, 2012
Table 2 Interpretive criteria for M haemolytica using broth microdilution susceptibility testing reported as minimum
inhibitory concentrations (μg/ml)
Antimicrobial Susceptible Intermediate Resistant Reference
Amikacin ≤16 32 ≥64 *CLSI M100-S22, 2012
Ampicillin ≤0.5 - - CLSI M45-A2, 2010
Amoxicillin-Clavulanate ≤0.5/0.25 - - CLSI M45-A2, 2010
Cefoxitin ≤8 16 ≥32 *CLSI M100-S22, 2012
Ceftiofur ≤2 4 ≥8 CSLI M31-A4, 2013
Ceftriaxone ≤1 2 ≥4 *CLSI M100-S22, 2012
Chloramphenicol ≤8 16 ≥32 *CLSI M100-S22, 2012
Ciprofloxacin ≤1 2 ≥4 *CLSI M100-S21, 2011
Gentamicin ≤4 8 ≥16 *CLSI M100-S22, 2012
Kanamycin ≤16 32 ≥64 *CLSI M100-S22, 2012
Nalidixic Acid ≤16 - ≥32 *CLSI M100-S22, 2012
Streptomycin ≤32 - ≥64 NARMS Executive Report 2009
Sulfisoxazole ≤256 - ≥512 *CLSI M100-S22, 2012
Tetracycline ≤2 4 ≥8 CLSI M31-A4, 2013
Trimethoprim-Sulfamethoxazole ≤0.5/9.5 - - CLSI M45-A2, 2010
*Interpretive criteria for E. coli used in lieu of M. haemolytica since CLSI does not define breakpoints for M. haemolytica and these antimicrobial drugs.
CLSI = Clinical and Laboratory Standards Institute.
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ated in parallel for each antimicrobial drug tested. Analysis
of the variance structure relative to the hierarchy of the
data (feedlot-pen-animal-isolate) revealed that almost all of
the clustering (correlation in resistance outcomes) occurred
at the isolate level (data not shown, MLwiN version 2.02,
Center for Multilevel Modeling, University of Bristol). As
such, lack of independence among isolates was controlled
in models using generalized estimating equations (GEE)
using an exchangeable correlation structure. Separate
models for each antimicrobial drug and for each methodo-
logical comparison were built using a priori understandings
of the hierarchical data structure using commerciallyTable 3 Interpretive criteria for E coli using disk diffusion suscep
Antimicrobial [Disk] (μg) Susceptible
Ampicillin 10 ≥17










*Interpretive criteria for M. haemolytica used in lieu of E. coli since CLSI does not de
CLSI = Clinical and Laboratory Standards Institute.available software (SAS version 9.2, SAS Institute Inc.,
Cary, NC). Odds ratios, 95% confidence intervals (95%
CI), and the associated P-values were obtained for each
model. Due to lack of precision in the estimates and the
impact on model stability, models were not evaluated if
resistance to a particular antimicrobial was less than 2%.
Isolates and data analyses
Susceptibility test comparison
Isolates evaluated by both susceptibility testing methods
(disk diffusion and broth microdilution) were included for
the comparison of detected differences in resistancetibility testing reported as inhibition zone diameters (mm)
Intermediate Resistant Reference
14-16 ≤13 CLSI M100-S22, 2012
14-17 ≤13 CLSI M100-S22, 2012
15-17 ≤14 CLSI M100-S18, 2008
18-20 ≤17 CLSI M31-A4, 2013
17-20 ≤16 *CLSI M31-A4, 2013
15-18 ≤14 *CLSI M31- A4, 2013
- ≤12 *CLSI M31-A3, 2008
12-14 ≤11 CLSI M100-S18, 2008
13-16 ≤12 CLSI M100-S22, 2012
12-14 ≤11 CLSI M31-A4, 2013
11-15 ≤10 CLSI M100-S22, 2012
fine breakpoints for E. coli in cattle for these antimicrobial drugs.
Table 4 Interpretive criteria for M haemolytica using disk diffusion susceptibility testing reported as inhibition zone
diameters in (mm)
Antimicrobial [Disk] (μg) Susceptible Intermediate Resistant Reference
Ampicillin 10 ≥27 - - CLSI M45-A2, 2010
Amoxicillin- Clavulanate 20/10 ≥27 - - CLSI M45-A2, 2010
Ceftiofur 30 ≥21 18-20 ≤17 CLSI M31-A3, 2008
Danofloxacin 5 ≥22 - - CLSI M31-A3, 2008
Enrofloxacin 5 ≥21 17-20 ≤16 CLSI M31-A4, 2013
Florfenicol 30 ≥19 15-18 ≤14 CLSI M31-A4, 2013
Gentamicin 10 ≥15 - ≤12 Catry et al., 2007
Spectinomycin 100 ≥14 11-13 ≤10 CLSI M31-A3, 2008
Sulfisoxazole 300 ≥17 13-16 ≤12 CLSI M31-A3, 2008
Tetracycline 30 ≥23 - - CLSI M45-A2, 2010
Tilmicosin 15 ≥14 11-13 ≤10 CLSI M31-A4, 2013
Trimethoprim-Sulfamethoxazole 1.25/23.75 ≥24 - - CLSI M45-A2, 2010
Tulathromycin 30 ≥18 15-17 ≤14 CLSI M31-A4, 2013
CLSI = Clinical and Laboratory Standards Institute.
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sion with matching on the isolate level was used to evaluate
the association between resistance to each AMD and sus-
ceptibility test. The type of susceptibility test was the only
predictor included in these models (automated disk diffu-
sion vs. broth microdilution). There were 7 AMDs that
could be analyzed in these models as these drugs were eval-
uated on both susceptibility panels (ampicillin, amoxicillin-
clavulanic acid, ceftiofur, streptomycin, sulfisoxazole, tetra-
cycline, and trimethoprim-sulfamethoxazole). Separate models
were analyzed for NTSEC recovered from individuals and
all M. haemolytica isolates.
Organism comparison
Isolates of NTSEC and M. haemolytica that were recovered
from the same individuals were evaluated in conditional logis-
tic regression models (matching on isolate) to investigate sys-
tematic differences in resistance for the two organisms. Only
susceptibility results from testing with broth microdilution
were included in these analyses. Separate models were
evaluated for each resistance outcome (i.e., drug) and or-
ganism was the only predictor included in these models
(NTSEC vs. M. haemolytica).
Sampling strategy comparison for NTSEC
To investigate the potential that there may be differences in
resistance prevalences among NTSEC recovered from indi-
vidual fecal samples when compared to those recovered from
composite (pen-floor) samples, isolates recovered from these
two sample types were compared using logistic regression.
Only susceptibility results from testing with broth
microdilution were included in these analyses. Lack of inde-
pendence among isolates was controlled in models using gen-
eralized estimating equations (GEE) using an exchangeablecorrelation structure. Separate models were evaluated for
each AMD and the sample type was the only predictor in-
cluded in these models (fecal samples collected per rectum
from individuals vs. composite fecal samples collected from
pen floors). Since pens were occasionally stocked over a
number of days, only the isolates that were recovered from
composite and individual samples that had been collected
on the same day were included in these analyses.
Selective testing of NTSEC isolates
Logistic regression was used to compare the likelihood for
detecting resistance prevalences among NTSEC recovered
from cattle that were culture-positive for M. haemolytica ver-
sus those that were culture-negative. Only susceptibility re-
sults from testing with broth microdilution were included in
these analyses. Only isolates collected from culture-positive
and culture-negative cattle that were housed in the same
pens and sampled within the same time frame were included
in these analyses. Lack of independence among isolates recov-
ered from individuals housed within the same pens was con-
trolled using GEE using an exchangeable correlation structure,
and separate models were investigated for each AMD. The
M. haemolytica culture status of individuals (culture-positive
vs. culture-negative) was included as the fixed effect of inter-
est, and additional predictor variables were controlled in the
analyses to account for potential differences in resistance that
might be associated with feedlot, sampling time-frame (i.e.,
first or second sample), and a single interaction term between
sample time-frame andM. haemolytica culture status.
Results
Antimicrobial susceptibility test comparison
A total of 3362 NTSEC isolates recovered from individual
fecal samples and 1574 M. haemolytica nasopharyngeal
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microdilution and disk diffusion. Results indicated that
there were strong differences in the likelihood of resistance
classification for NTSEC isolates from individual fecal sam-
ples for 5 of 6 AMDs (Table 5). Automated disk diffusion
was more likely than broth microdilution to classify the iso-
lates as resistant to ampicillin, to ceftiofur, to streptomycin,
and to trimethoprim-sulfamethoxazole. However, disk
diffusion was less likely to classify NTSEC isolated from
individual samples as tetracycline resistant than broth
microdilution. The model for amoxicillin-clavulanic acid
would not converge, presumably because of the low preva-
lence of resistance (<2%).
There were also strong differences in the likelihood of
detecting resistance for M. haemolytica, where automated
disk diffusion was more likely than broth microdilution to
classify resistance to ampicillin, amoxicillin-clavulanic
acid, and tetracycline. Models for ceftiofur, streptomycin,
sulfisoxazole, and trimethoprim-sulfamethoxazole did not
converge, presumably because of the low prevalence of
resistance (all were <2%).
Organism comparison
Isolates of NTSEC and M. haemolytica that were both
recovered from the same 2190 individuals were identified
for this comparison and evaluated by broth microdilution.
Results indicate that there was a strong statistically detect-






Ampicillin DD3 6.3 2.9 –
BM4 ref
Amoxicillin-Clavulanate DD −5 –
BM
Ceftiofur DD 5.6 1.2 –
BM ref
Streptomycin DD 2.0 1.6 –
BM ref
Sulfisoxazole DD 1.3 0.9 –
BM ref
Tetracycline DD 0.6 0.5 –
BM ref
TMS6 DD 4.8 2.0 –
BM ref
1Odds ratio comparing disk diffusion to broth microdilution as the reference catego
295% confidence intervals determined using Wald statistics.
3Disk Diffusion.
4Broth Microdilution.
5Model was not stable because of low resistance prevalence.
6Trimethoprim-Sulfamethoxazole.NTSEC for all drugs except nalidixic acid, when compared
to M. haemolytica (Table 6). Non-type specific E. coli was
much more likely to be classified as resistant to ampicillin,
streptomycin, sulfisoxazole, tetracycline, and trimethoprim-
sulfamethoxazole, but M. haemolytica was more likely
than NTSEC to be classified as resistant to kanamycin.
Resistance in other drugs could not be compared in these
analyses because of low resistance prevalence which created
instability in regression models (amikacin, amoxicillin-
clavulanate, cefoxitin, ceftiofur, ceftriaxone, chloramphenicol,
ciprofloxacin, gentamicin, and nalidixic acid).
Sampling strategy comparison
A total of 412 NTSEC recovered from 137 individual fecal
samples collected per rectum on the second sampling day
were used in this analysis, along with 198 NTSEC isolates
collected from 40 composite pen-floor samples that were
collected from the same pens on the same days. Controlling
for the lack of independence created by analyzing multiple
isolates from the same sample and obtaining multiple sam-
ples from cattle housed in the same pen, the proportion of
resistant isolates was not different for any of the drugs evalu-
ated (ampicillin, chloramphenicol, kanamycin, nalidixic acid,
streptomycin, sulfisoxazole, tetracycline, and trimethoprim-
sulfamethoxazole; P>0.30; Table 7). Resistance in other
drugs could not be compared in these analyses because
of low resistance prevalence which created instability
in regression models (amikacin, amoxicillin-clavulanate,EC or M Haemolytica when tested using disk diffusion
(n=3362) M. haemolytica (n=1574)
CI2 P-value OR1 95% CI2 P-value
14.3 <0.0001 20.0 5.0 – 100 <0.0001
ref
– 10.0 3.0 – 33.3 0.0001
ref
25.0 0.03 −5 – –
2.7 <0.0001 −5 – –
1.9 0.11 −5 – –
0.8 0.0003 25.0 7.7 – 100 <0.0001
ref
11.1 0.0004 −5 – –
ry.
Table 6 Likelihood of identifying resistance among paired
isolates of NTSEC and M haemolytica that were recovered
from the same individuals on the same day (n=2190)1
Resistance
outcome2
Organism OR3 95% CI4 P-value
Ampicillin NTSEC 3.1 2.0 - 4.8 <0.0001
M. haemolytica Reference
Kanamycin NTSEC 0.2 0.1 - 0.3 <0.0001
M. haemolytica Reference
Nalidixic acid NTSEC 4.0 0.8 - 20.0 0.08
M. haemolytica Reference
Streptomycin NTSEC 3.3 3.3 - 10.7 <0.0001
M. haemolytica Reference
Sulfisoxazole NTSEC 50.0 25.0 - 100.0 <0.0001
M. haemolytica Reference




NTSEC 11.1 2.7 - 50.0 0.001
M. haemolytica Reference
1Susceptibility testing was performed using broth microdilution.
2Other drugs could not be analyzed because of low resistance prevalence
(amikacin, amoxicillin-clavulanate, cefoxitin, ceftiofur, ceftriaxone,
chloramphenicol, ciprofloxacin, gentamicin, and nalidixic acid).
3Odds ratio.
495% confidence intervals determined using Wald statistics.
Table 7 Likelihood of identifying resistance among NTSEC
isolates cultured from feces collected as composite pen
floor samples or as individual samples collected per





OR4 95% CI5 P-value
Ampicillin Individual 0.8 0.3 – 1.8 0.58
Composite Reference
Chloramphenicol Individual 0.9 0.4 – 2.5 0.94
Composite Reference
Kanamycin Individual 0.6 0.2 – 2.5 0.5
Composite Reference
Nalidixic Acid Individual 3.5 0.3 – 44.8 0.41
Composite Reference
Streptomycin Individual 1.3 0.8 – 2.2 0.31
Composite Reference
Sulfisoxazole Individual 1.2 0.7 – 2.2 0.5
Composite Reference




Individual 1.7 0.4 – 8.5 0.5
Composite Reference
1n=412 isolates recovered from 137 fecal samples collected from individual
cattle, and n=198 isolates recovered from 40 composite pen floor
fecal samples.
2Susceptibility testing was performed using broth microdilution.
3Other drugs could not be analyzed because of low resistance prevalence
(amikacin, amoxicillin-clavulanate, cefoxitin, ceftiofur, ceftriaxone, ciprofloxacin,
gentamicin, and nalidixic acid).
4 Odds Ratio. Analyses controlled for potential lack of independence related to
repeated measures and hierarchical data structure using generalized
estimating equations.
595% confidence intervals.
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and nalidixic acid).
Selective testing of E. Coli isolates
The NSTEC isolates used in this comparison were re-
covered from a total of 186 cattle (n=377 isolates) that
were culture-positive for M. haemolytica and 77 that were
culture-negative (n=225 isolates). Modeling as described,
results indicated that there was no detectable difference
in the proportion of resistant isolates when comparing
NTSEC isolates recovered from these 2 groups (Table 8).
Resistance in other drugs could not be compared in
these analyses because of low resistance prevalence
which created instability in regression models (amikacin,
amoxicillin-clavulanate, cefoxitin, ceftiofur, ceftriaxone,
chloramphenicol, ciprofloxacin, gentamicin, kanamycin,
nalidixic acid, trimethoprim-sulfamethoxazole).
Discussion
This study was performed because of the practical
questions that naturally arose when attempting to de-
sign a large-scale surveillance program for AMR in
beef feedlot cattle. Specifically these questions were:
Does it matter which susceptibility testing methods are
used? Is resistance different for enteric surveillance
targets compared to testing of a respiratory pathogen?
How should fecal samples be collected? And, does selectivesampling of cattle bias results? These results suggest the
method for evaluating susceptibility and the target bacteria
chosen for surveillance programs must be considered
carefully relative to the purpose for conducting surveil-
lance, as these choices will systematically affect the results
of the investigations. However, there was no difference in
resistance estimates obtained from fecal samples collected
per rectum or as composite pen floor samples, nor did
M. haemolytica culture status affect results related to
resistance in NTSEC. Thus surveillance programs could
be flexible relative to these factors.
As with all work involving in vitro test results for
antimicrobial resistance, analyses were heavily dependent
upon interpretive criteria used in classifying susceptibility
of isolates. Ideally, breakpoints specific to animal species,
disease, pathogen, drug, and the administration regimen
(dose, route, duration, and frequency) should be used
for the most clinically valid interpretations. However,
approved guidelines have not been defined for all of the
antimicrobial drugs tested in this study regarding feedlot
cattle. Therefore, each antimicrobial drug was carefully
Table 8 Likelihood of identifying resistance among
NTSEC isolates recovered from individuals that were
culture-positive for M haemolytica to those that were








OR5 95% CI6 P-value
Ampicillin First Positive 1.2 0.3 – 4.8 0.78
Negative ref
Second Positive 3.3 0.4 – 26.8 0.19
Negative ref
Streptomycin First Positive 0.4 0.2 – 0.9 0.04
Negative ref
Second Positive 0.5 0.1 – 2.3 0.46
Negative ref
Sulfisoxazole First Positive 0.8 0.4 – 1.7 0.56
Negative ref
Second Positive 1.5 0.5 – 4.4 0.50
Negative ref
Teteracyline First Positive 1.1 0.5 – 2.5 0.82
Negative ref
Second Positive 0.9 0.4 – 2.2 0.90
Negative ref
1n=377 isolates recovered from 186 individuals that were culture-positive for
MH, and n=225 isolates recovered from 77 individuals that were
culture-negative for MH.
2Susceptibility testing was performed using broth microdilution.
3Other drugs could not be analyzed because of low resistance prevalence
(amikacin, amoxicillin-clavulanate, cefoxitin, ceftiofur, ceftriaxone,
chloramphenicol, ciprofloxacin, gentamicin, kanamycin, nalidixic
acid, trimethoprim-sulfamethoxazole).
4Culture status regarding recovery of M. haemolytica from
nasopharyngeal swabs.
5Analyses controlled for repeated measures and hierarchical data structure
using generalized estimating equations (GEE), and fixed effects for feedlot,
sample time, M. haemolytica culture-status, and a single interaction term for
sample time*M. haemolytica culture-status.
695% confidence intervals.
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identify appropriate CLSI interpretive criteria when possible
and published acceptable alternatives when CLSI criteria
were not defined (Tables 1, 2, 3 and 4). The biological
differences between these organisms likely contribute to
whether each is resistant (or not) to specified concentra-
tions of antimicrobial drug. Therefore, the breakpoint
differences relative to the organism may affect or even
bias the results of these comparisons. The very large
differences in the proportion of resistant isolates when
comparing the two target organisms likely represent
real differences, but the magnitude of these differences
might change if different breakpoints were used (such
as epidemiological breakpoints) [24].
A low prevalence of resistance to many of drugs evaluated
in this study has been previously described in NTSEC and
M. haemolytica recovered from feedlot cattle and thereforewas not unexpected [11,12,25,26]. However, this low
resistance prevalence limited the ability to make infer-
ences regarding our research questions with all of the
drugs that were evaluated. Regardless, given the diver-
sity of drugs that were included these analyses and the
low prevalence that has been documented in multiple
studies, it seems unlikely that contradictory findings
would be obtained if we had been able to include these
drugs in the regression modeling.
While there were differences noted by directly comparing
the detection of resistance with broth microdilution or disk
diffusion, these observations cannot be extrapolated to
provide unbiased estimates of test accuracy (sensitivity
and specificity), as neither can be considered a perfect
reference. Therefore, while these results showed that for
most of the drugs evaluated there were strong differences
in the likelihood classifying organisms as being resistant,
the superiority of one test over the other for correct classi-
fication of resistance cannot be asserted. Again, the inter-
pretive criteria used in this study could have affected the
estimates for resistance classification. While the interpret-
ive criteria established by CLSI are intended to provide
the same classification results for broth microdilution and
disk diffusion when comparing test results for the same
isolates and extreme care was used to ensure that ap-
propriate breakpoints were used throughout this inves-
tigation, results could have been affected by the absence
of standardized criteria for all bacteria-drug combina-
tions and specifically defined for cattle. Other studies
have evaluated the MICs estimated by algorithms based
on the zone diameters and compared them to the MICs
determined by broth microdilution to show both close
agreement as well as widely divergent results [27,28].
Interestingly, results regarding tetracycline resistance
indicated that broth microdilution was more likely to
classify tetracycline resistance in NTSEC whereas disk
diffusion was more likely to classify tetracycline resistance
in M. haemolytica. These differences could partially be at-
tributed to the previously discussed biological differences
between the organisms as well as the detection differences
between the susceptibility tests.
Investigations of AMR in animal populations have much
greater relevance to producers if important bacterial path-
ogens are incorporated in surveillance efforts alongside
monitoring an indicator of AMR for the purposes of public
health surveillance. However, based on previous research,
it was known that the M. haemolytica would not be re-
coverable from all cattle, while NTSEC is ubiquitous
[12]. Therefore, as a measure to aid efficiency and cost-
effectiveness in the larger surveillance program within
which these investigations were nested, it was decided
to only recover NTSEC from the individuals that were
culture-positive for M. haemolytica. The ability to recover
M. haemolytica might be related to the treatment history
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in the feeding period). Further, the ability to recover this
bacterium could also be related to its resistance status.
Therefore, a direct comparison between M. haemolytica
positive and M. haemolytica negative NTSEC isolates was
warranted to verify if results might be biased by the design
consideration to only recover NTSEC from individuals
culture positive for M. haemoltyica. Other factors were
also controlled in these analyses which may have affected
the likelihood of detecting resistant NTSEC. Even though
the interaction (sample time*M. haemolytica status) was not
found to be statistically significant in any of the models, it
was still forced into models due to its biological relevance.
There was wide variability in the timing of when the
second samples were collected because this sampling
was coordinated with the need to restrain and handle
individual cattle for routine management procedures
(i.e., re-implanting) This routine handling occurs at differ-
ent times because of variability in cattle weights/ages
and sex, in addition to the practical logistics of man-
aging large feedlots. Regardless, this variability should
not have systematically altered results of this study as
comparisons of multiple bacterial isolates recovered
from individual cattle were limited to those recovered
on the same day (i.e., fecal and nasopharyngeal samples
were collected on the same day). Also, for comparisons of
NSTEC isolates recovered from cattle that were culture-
positive or culture-negative for M. haemolytica, the dis-
tributions of sampling days (DOF) were similar and sam-
pling time was included as a variable in the analysis.
Conclusions
We found that for use in AMR surveillance, the susceptibil-
ity test must be carefully chosen considering the purpose of
the surveillance since the ability to correctly classify target
organisms apparently can vary between these tests. This
study was not designed to evaluate the accuracy of either
test, but this investigation demonstrates that results for the
two tests varied among the different drugs. Surveillance of
AMR in M. haemolytica recovered from feedlot cattle is ap-
propriate in order to improve the relevance by inclusion of
an animal health pathogen, especially since AMR in NTSEC
does not predict results for M. haemolytica. Sampling
strategies used in AMR surveillance for NTSEC recovered
from feedlot cattle could possibly employ composite pen
floor fecal sampling interchangeably with sampling feces
from individual cattle per rectum. Feces could be sampled
from individuals to recover NTSEC without regard for
M. haemolytica culture status as an efficiency when both
agents are targets for surveillance.
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